April 16, 2026
Biosimilar Monoclonal Antibodies Market (By Type: Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others; By Indication: Oncology, Autoimmune diseases, Others; By End User: Hospitals, Cancer treatment centers, Others; By Region: North Am...
April 17, 2026
Biosimilar Contract Manufacturing Market (By Source: Mammalian, Non-mammalian; By Services: Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins; By Therapeutic Area: Oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic ...
April 07, 2026
Biosimilars Market ( By Product: Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins; By Application: Chronic & Autoimmune Disorders Oncology, Blood Disorders, Growth Hormonal Deficiency, Rheumatoid Arthritis, Others; By Regi...
April 21, 2026
The human insulin market is expanding steadily, rising from USD 20.97 billion in 2026 to USD 27.68 billion by 2035 at a CAGR of 3.13%, driven by increasing diabetes cases globally. This report covers complete segmentation by product, formulation, end...
April 21, 2026
Projections indicate that, the global aflibercept biosimilars market will increase from USD 1.54 billion in 2024 to USD 3.7 billion by 2034, experiencing a CAGR of 9.14% over the next 10 years. The maturing ophthalmic biosimilar ecosystem is estimate...
April 21, 2026
According to market estimations the global generic sterile injectable market was estimated at US$ 51.23 billion in 2025 and is projected to grow to US$ 82.14 billion by 2030. In 2023, North America led the market with a 40% share. Monoclonal antibodi...
April 21, 2026
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com